This grant opportunity, PAR-25-297 (CFDA: 93.866), focuses on Alzheimer's drug development and includes an optional clinical trial component. Funding is provided by HHS-NIH11 to support research in this area.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.